Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer

Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer

Abstract Background Preclinical data suggest that oncogene (EGFR and KRAS) events regulate tumor procoagulant activity. However, few studies have prospectively investigated the clinical relevance between the presence of EGFR or KRAS mutations and occurrence of venous thromboembolism(VTE) in patients...

Full description

Bibliographic Details
Main Authors: Feifei Dou, Huiqiao Li, Min Zhu, Lirong Liang, Yuan Zhang, Jiawen Yi, Yuhui Zhang
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Respiratory Research
Subjects:
Non-small cell lung cancer
Venous thromboembolism
Mutation
Oncogene
Epidermal growth factor receptor
Kitten rat sarcoma
Online Access:http://link.springer.com/article/10.1186/s12931-018-0791-2

Internet

http://link.springer.com/article/10.1186/s12931-018-0791-2

Similar Items